Brain Infarction Clinical Trials

4 recruiting

Brain Infarction Trials at a Glance

8 actively recruiting trials for brain infarction are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Bern, Wuhan, and Beijing. Lead sponsors running brain infarction studies include Insel Gruppe AG, University Hospital Bern, Chinese Academy of Medical Sciences, Fuwai Hospital, and Capital Medical University.

Browse brain infarction trials by phase

Treatments under study

About Brain Infarction Clinical Trials

Looking for clinical trials for Brain Infarction? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Brain Infarction trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Brain Infarction clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

earlY Upper Limb Rehabilitation WIth EEG-Neurofeedback After Stroke

Stroke RehabilitationStroke, IschemicStroke+2 more
Rennes University Hospital40 enrolled1 locationNCT05884762
Recruiting
Phase 3

Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy(RECAST-MT)

Acute Ischemic StrokeAnterior Circulation Brain Infarction
Capital Medical University2,105 enrolled56 locationsNCT06559241
Recruiting
Phase 3

A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)

Covert Brain Infarction
Aarhus University Hospital1,652 enrolled14 locationsNCT07012629
Recruiting
Not Applicable

Interventions for Silent Brain Infarction and Perioperative Neurocognitive Disorders in Cardiovascular Surgery

Neurocognitive DisordersCardiac SurgeryNeuroprotective+1 more
Chinese Academy of Medical Sciences, Fuwai Hospital912 enrolled5 locationsNCT07048002
Recruiting

Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation

Brain DiseasesCentral Nervous System DiseasesAtrial Fibrillation+11 more
Insel Gruppe AG, University Hospital Bern500 enrolled1 locationNCT06954610
Recruiting

Prevalence of Attributable Etiology and Modifiable Stroke Risk Factors in Patients With Covert Brain Infarctions

Silent StrokeSilent Cerebral InfarctCovert Brain Infarct+3 more
Insel Gruppe AG, University Hospital Bern230 enrolled2 locationsNCT05685069
Recruiting

Therapy Evaluation in Patients With Minor Stroke and Large Vessel Occlusion

Brain DiseasesCentral Nervous System DiseasesCerebrovascular Disorders+4 more
Sir Run Run Shaw Hospital200 enrolled1 locationNCT06633809
Recruiting
Phase 4

For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide.

Central Nervous System DiseasesStrokeNervous System Diseases+4 more
Qianfoshan Hospital300 enrolled1 locationNCT05068349